Infectious
Herpes Simplex
Herpes Simplex is an infectious condition. The outcome discussed here is herpes labialis, commonly called cold sores.
Herpes Simplex is categorized as an infectious condition, offering a focused starting point for understanding the topic.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
1 option:1 some evidence
Red Light Therapy (Photobiomodulation)practiceSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 3 studies with a clear result found a benefit.
A pooled analysis of six randomized trials in people with herpes labialis reported benefit compared with conventional antiviral treatment. For recurrence prevention, a review found benefit on frequency in two of three trials.
Open the Red Light Therapy (Photobiomodulation) page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedMost likely to help, from the evidence we have
- →PracticesRed Light Therapy (Photobiomodulation)CertaintyMediumSourceRCT
A pooled analysis of six randomized trials in people with herpes labialis reported benefit compared with conventional antiviral treatment. For recurrence prevention, a review found benefit on frequency in two of three trials.
Who was studied
- People with a condition
- Herpes Simplex
Open Red Light Therapy (Photobiomodulation)Study result
Meta-analysis of six RCTs in patients with herpes labialis showing PBMT benefit versus conventional antiviral treatment.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Herpes Simplex worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Herpes Simplex is an infectious condition. The outcome discussed here is herpes labialis, commonly called cold sores. What a person may notice includes symptom severity and the time needed for the sores to heal. These describe the course of an episode rather than representing separate conditions.
Evidence-backed options
The option associated with Herpes Simplex is topical Lemon Balm (Melissa) extract. Its reported use is specific to herpes labialis, commonly called cold sores, rather than to every presentation of herpes simplex. The finding describes shorter healing time and reduced symptom severity, but the evidence label is low, so the result should be interpreted cautiously.
The available reference does not specify the amount used, how often it was applied, treatment duration, or how quickly effects appeared. It also does not identify the health status of the people studied. These limits make it difficult to determine how broadly the finding applies. A clinician can help interpret whether an option is relevant to an individual medical condition.
What to avoid
Citrulline is flagged for caution with Herpes Simplex because it increases arginine levels. Higher arginine may promote replication of herpes simplex virus, which could potentially trigger outbreaks in susceptible individuals. This concern relates to a possible effect on viral activity rather than an established outcome for everyone with the condition.
People with Herpes Simplex may wish to discuss the relevance of Citrulline with a clinician, particularly if outbreaks are recurrent or if the supplement is being considered for another purpose. Individual susceptibility and overall treatment context may affect whether this potential concern is meaningful.